Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Cash flows from operating activities
Net loss	$ (49,527)	$ (42,815)	$ (20,552)
Adjustments to reconcile net loss to net cash used in operating activities
Depreciation and amortization expense	5,352	2,133	685
Provision for allowance for doubtful accounts	434	411	144
Share-based compensation expense	17,352	8,111	3,409
Non-cash lease expense	2,461	2,522	0
Amortization of debt issuance costs	297	244	176
Gain on fair value adjustment to derivative liability	0	(173)	(72)
Debt extinguishment loss	0	4,483	0
Loss on impairment of long-lived assets	0	346	0
Accretion (amortization) of discount (premium) on marketable securities, net	(1,406)	(126)	0
Other, net	205	25	0
Net changes in operating assets and liabilities, net of acquisitions:
Accounts Receivable	(9,301)	(11,039)	(4,226)
Inventory	(9,848)	(8,769)	(2,741)
Prepaid expenses and other assets	(1,210)	(668)	(2,417)
Other non-current assets	0	(146)	0
Other liabilities	(119)	3,076	0
Accounts payable	3,167	4,612	1,791
Accrued liabilities	7,528	7,125	6,610
Other, net	40	0	0
Net cash used in operating activities	(34,575)	(30,648)	(17,193)
Cash flows from investing activities
Purchases of available-for-sale marketable securities	(169,865)	(63,409)	0
Sales and maturities of available-for-sale marketable securities	120,024	1,729	0
Purchases of property and equipment	(11,458)	(14,838)	(2,705)
Acquisition, net of cash acquired	(20,000)	0	0
Net cash used in investing activities	(81,299)	(76,518)	(2,705)
Cash flows from financing activities
Proceeds from interest bearing term debt	0	49,651	0
Proceeds from interest bearing revolving debt	0	3,850	0
Debt issuance costs	0	(989)	0
Payments on interest bearing debt	0	(33,893)	0
Payments on PPP Loan	0	0	(1,788)
Proceeds from issuance of common stock from public offering, net of issuance costs and underwriting discount of $7.5 million and $10.6 million	107,527	0	107,610
Proceeds from exercise of employee stock options	1,869	2,187	1,830
Taxes from withheld shares	(13)	0	0
Net cash provided by financing activities	109,383	20,806	107,652
Net decrease in cash and cash equivalents	(6,491)	(86,360)	87,754
Cash and cash equivalents at beginning of period	19,473	105,833	18,079
Cash and cash equivalents at end of period	12,982	19,473	105,833
Supplemental disclosure of cash flow information:
Cash paid for interest	5,167	4,398	3,900
Operating lease right-of-use assets obtained in exchange for new lease liabilities	0	15,300	0
Operating lease right-of-use asset and lease liability adjustment due to lease incentive	(22)	3,615	0
Noncash investing activities and financing activities:
Unrealized (gains) losses on marketable securities	(190)	27	0
Unsettled matured marketable security and receivable from broker	3,000	0	0
Noncash portion of internally developed software	(11)	0	0
Issuance of common stock upon exercise of warrants	0	0	1
Conversion of convertible preferred stock and accrued dividends on convertible preferred stock into common stock	$ 0	$ 0	$ 7,935